Vericel
$36.94
22
+$0.96+2.67% Monday 21:00
Statistics
Day High
37.15
Day Low
35.82
52W High
63
52W Low
29.24
Volume
315,737
Avg. Volume
608,213
Mkt Cap
1.87B
P/E Ratio
250.43
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26FebExpected
Expected EPS
0.390775
Actual EPS
N/A
Financials
4.37%Profit Margin
Profitable474.45MRevenue
20.72MNet Income
Analyst Ratings
$45.00Average Price Target
The highest estimate is 45.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow VCEL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap1.13B
Brainstorm Cell Therapeutics
BCLI
Mkt Cap6.74M
Mesoblast
MESO
Mkt Cap2.14B
Fate Therapeutics
FATE
Mkt Cap155.7M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
About
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Dominick C. Colangelo Esq.
Employees
357
Country
US
ISIN
US92346J1088
Listings
0 Comments
Share your thoughts
FAQ
What is Vericel stock price today?▼
The current price of VCEL is $36.94 USD — it has increased by +2.67% in the past 24 hours. Watch Vericel stock price performance more closely on the chart.
What is Vericel stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vericel stocks are traded under the ticker VCEL.
Is Vericel stock price growing?▼
VCEL stock has risen by +0.98% compared to the previous week, the month change is a +3.73% rise, over the last year Vericel has showed a -37.45% decrease.
What is Vericel market cap?▼
Today Vericel has the market capitalization of 1.87B
When is the next Vericel earnings date?▼
Vericel is going to release the next earnings report on February 26, 2026.
What were Vericel earnings last quarter?▼
VCEL earnings for the last quarter are 0.1 USD per share, whereas the estimation was -0.01 USD resulting in a +1,693.63% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vericel revenue for the last year?▼
Vericel revenue for the last year amounts to 474.45M USD.
What is Vericel net income for the last year?▼
VCEL net income for the last year is 20.72M USD.
How many employees does Vericel have?▼
As of February 03, 2026, the company has 357 employees.
In which sector is Vericel located?▼
Vericel operates in the Health Care sector.
When did Vericel complete a stock split?▼
The last stock split for Vericel was on October 16, 2013 with a ratio of 1:20.
Where is Vericel headquartered?▼
Vericel is headquartered in Cambridge, US.